Adc Therapeutics
(NYSE) ADCT
Adc Therapeutics Financials at a Glance
Market Cap
$132.28M
Revenue (TTM)
$79.18M
Net Income (TTM)
-$136.99M
EPS (TTM)
-$1.05
P/E Ratio
-0.99
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$1.03
Volume
4,447,685
Open
$1.02
Price
$1.03
Volume
4,447,685
Open
$1.02
Previous Close
$1.02
Daily Range
$1.00 - $1.07
52-Week Range
$0.78 - $4.98
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$1.03
Volume
4,447,685
Open
$1.02
Previous Close
$1.02
Daily Range
$1.00 - $1.07
52-Week Range
$0.78 - $4.98
Estimated Earnings Date
Aug 11, 2026
ADCT News
ADCT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Adc Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
193
CEO
Ameet Mallik, MBA
Website
www.adctherapeutics.comHeadquarters
Epalinges, 1066, CH
ADCT Financials
Key Financial Metrics (TTM)
Gross Margin
90.71%
Operating Margin
-148.84%
Net Income Margin
-173.02%
Return on Equity
65.27%
Return on Capital
-42.81%
Return on Assets
-47.00%
Earnings Yield
-1.01%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$132.28M
Shares Outstanding
127.19M
Volume
4.45M
Avg. Volume
1.74M
Financials (TTM)
Gross Profit
$71.82M
Operating Income
-$117.84M
EBITDA
-$83.20M
Operating Cash Flow
-$114.55M
Capital Expenditure
-$45.77K
Free Cash Flow
-$114.59M
Cash & ST Invst.
$231.01M
Total Debt
$116.67M
Adc Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$20.85M
-9.5%
Gross Profit
$17.24M
-17.8%
Gross Margin
82.66%
N/A
Market Cap
$132.28M
N/A
Market Cap/Employee
$502.96K
N/A
Employees
263
N/A
Net Income
-$32.97M
+14.6%
EBITDA
-$20.51M
+20.2%
Quarterly Fundamentals
Total Cash
$231.01M
+18.6%
Total Debt
$116.67M
-74.1%
Accounts Receivable
$31.05M
-2.3%
Inventory
$4.78M
-72.6%
Long Term Debt
$112.03M
-75.0%
Short Term Debt
$4.64M
+238.8%
Return on Assets
-47.00%
N/A
Return on Invested Capital
-52.64%
N/A
Free Cash Flow
-$29.74M
+47.5%
Operating Cash Flow
-$29.71M
+47.3%